阿奇霉素与阴道栓剂联合在非淋菌性宫颈炎治疗中的临床疗效观察

来源 :健康之友 | 被引量 : 0次 | 上传用户:qiangchengshimeng
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察非淋菌性宫颈炎患者采用阿奇霉素与阴道栓剂联合方案治疗的临床效果。方法:随机筛选来我医院接受治疗的90例非淋菌性宫颈炎患者,通过电脑随机数字表法将纳入的患者划分为45例观察组和45例对照组,对照组患者治疗采用阿奇霉素,观察组患者运用阿奇霉素与阴道栓剂联合方案治疗,将最终两组治疗效果进行比对。结果:治疗后与对照组指标比较后发现,观察组患者临床症状改善所用时间较短,经检测患者病原菌转阴率较高,治疗后一年内复发率较低,患者的治疗总有效率显著提升,以上指标结果与对照组相比均占据显著优势,两组指标对比存在统“,”Objective:To observe the clinical effect of Azithromycin combined with vaginal suppository in the treatment of non gonococcal cervicitis.Methods:90 patients with non gonococcal cervicitis who came to our hospital for treatment were randomly selected.The included patients were divided into 45 observation group and 45 control group by computer random number table.The patients in the control group were treated with azithromycin,and the patients in the observation group were treated with azithromycin and vaginal suppository.The therapeutic effects of the two groups were compared.Results:after treatment,compared with the control group,it was found that the observation group took a shorter time to improve clinical symptoms,the negative rate of pathogens was higher,the recurrence rate was lower within one year after treatment,and the total effective rate of patients was significantly improved.The above index results occupied a significant advantage compared with the control group.There was statistical significance in the comparison of the two groups(P0.05).Conclusion:Azithromycin combined with vaginal suppository can achieve ideal therapeutic effect in patients with non gonococcal vaginitis,help patients improve clinical symptoms and improve the cure efficiency in a short time.
其他文献
焦化行业烟气脱硝治理技术普遍采用SCR法,为解决中低温烟气工况下脱硝性能稳定达标,延长中低温脱硝催化剂的运行周期,降低过程能耗.采用X射线荧光光谱、热重、SEM、XPS和BET等手段对山西某焦化厂中低温SCR脱硝中的非钒系列化剂进行理化性能表征,阐述了中低温含SO2烟气工况下SCR脱硝催化剂失活的现象.结果表明:在中低温含SO2烟气工况下,SCR脱硝催化剂性能下降主要原因是表面存在粘性的硫酸氢铵,覆盖催化剂微孔,进而致使催化剂有效比表面积下降.
At present, multi-channel electroencephalogram ( EEG) signal acquisition equipment is used to collect motor imagery EEG data, and there is a problem with selecting multiple acquisition channels. Choosing too many channels will result in a large amount of
In a real communication scenario, it is very difficult to obtain the real-time channel state infor-mation ( CSI) accurately, so the non-orthogonal multiple access ( NOMA) system with statistical CSI has been researched. Aiming at the problem that the maxi
苯酚丙酮装置排放的含酚污水由于具有盐浓度高、有机物浓度高、生物毒性高的特点,是一种成分复杂、较难处理的化工污水.本文采用“高含盐污水→两级气浮→芬顿预处理→均质调节→微氧预曝气→水解酸化→A/O→臭氧氧化→高密沉淀池→臭氧催化氧化→生物滤池”的专有高盐废水生化处理技术,对某炼化一体化企业产生的苯酚丙酮等高含盐污水进行处理,出水可达标排放.
The development of network and information technology has brought changes to the information environment. The sources of information are becoming more diverse, and intelligence acquisition will be more complicated. The intelligence reflected by different
Graph embedding aims to map the high-dimensional nodes to a low-dimensional space and learns the graph relationship from its latent representations. Most existing graph embedding methods focus on the topological structure of graph data, but ignore the sem
Recently, Internet of Things ( IoT) have been applied widely and improved the quality of the daily life. However, the lightweight IoT devices can hardly implement complicated applications since they usually have limited computing resource and just can exe
目的:研究血常规标本临检前混匀静置时间对检验结果的影响。方法:选取本院检验科接收的60例血常规检验患者(2020年3月-2021年3月),待患者血液标本采集完成后,将血液标本静置30min、60min、120min、180min以及360min后展开血常规检验。结果:静置180min内血小板计数、白细胞计数以及中性粒细胞比值差异不明显(P>0.05);相比静置180min内,静止360min血小板计数以及中性粒细胞比值更低,白细胞计数更高,存在显著差异(P0.05);compared to within
目的:探讨布地奈德福莫特罗粉剂与噻托溴铵联合治疗稳定期慢阻肺合并糖尿病疾病的效果。方法:在2020年5月至2021年5月时段拟定并实行此次研究,配合人员为医院接收的稳定期慢阻肺合并糖尿病患者72例,依据双盲法分组,每组各有36例患者。分析比对整体效果、血糖水平、并发症情况、肺功能指标等指标。结果:联合治疗的研究组患者整体效果为97.22%(35/36)较参照组为75.00%(27/36)高,差异显著(p<0.05);各血糖水平在治疗前比对无差异(p>0.05),研究组各血糖水平在治疗后较参照组低(p<0.
目的:研究阿立哌唑合并碳酸锂在急性躁狂发作患者中的治疗效果。方法:选取我院2019年3月至2020年5月诊治的68例急性狂躁发作患者,根据治疗方式的不同,将其分成研究组与对照组,每组34例。对照组应用氨氯地平联合碳酸锂进行治疗,研究组应用阿立哌唑联合碳酸锂进行治疗,对比两组临床疗效、倍克-拉范森躁狂量表(BRMS)评分、不良反应量表(TESS)评分。结果:研究组治疗有效率(97.06%)高于对照组(79.41%),P<0.05。治疗前两组BRMS、TESS评分无差异,P>0.05,治疗后1个月、2个月研究